BMY Competitors & Alternatives
Compare Bristol-Myers Squibb Company with similar stocks in the same industry
Drug Manufacturers - General
BMY
Main Stock$63.64
Tradestie Score
34
Market Cap
$96.54B
P/E Ratio
14.0
Revenue Growth
0.1%
Analyst Upside
+4.0%
Top Competitors
17 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NVS
Novartis AG
|
$137.16
|
$254.99B | 20.7 | 42 | Compare |
|
ABT
Abbott Laboratories
|
$101.95
|
$232.30B | 34.0 | 41 | Compare |
|
MRK
Merck & Co., Inc.
|
$143.93
|
$225.13B | 117.7 | 42 | Compare |
|
AMGN
Amgen Inc
|
$377.35
|
$160.70B | 24.3 | 43 | Compare |
|
PFE
Pfizer Inc.
|
$27.72
|
$154.70B | 36.4 | 48 | Compare |
|
GILD
Gilead Sciences Inc
|
$143.72
|
$137.92B | - | 44 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$42.77
|
$121.27B | 22.7 | 39 | Compare |
|
GSK
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
|
$48.13
|
$91.59B | 15.1 | 39 | Compare |
|
BIIB
Biogen Inc. Common Stock
|
$217.15
|
$22.61B | 37.5 | 47 | Compare |
|
GRFS
Grifois, S.A.
|
$7.55
|
$6.78B | 10.2 | 49 | Compare |
More BMY Analysis
Data updated: Sep 12, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
17 stocks in this industry